USNA — USANA Health Sciences Cashflow Statement
0.000.00%
Last trade - 00:00- $550.31m
- $447.81m
- $854.50m
- 96
- 91
- 55
- 95
Annual cashflow statement for USANA Health Sciences, fiscal year end - December 28th, USD millions except per share, conversion factor applied.
2021 January 2nd | 2022 December 31st | 2022 January 1st | 2023 December 30th | 2024 December 28th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 125 | 69.3 | 117 | 63.8 | 42.1 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 23.9 | 21.5 | 23.5 | 24.9 | 24.1 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.556 | 6.85 | -28.9 | -28 | -13 |
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 160 | 104 | 121 | 70.6 | 61 |
| Capital Expenditures | -15.1 | -16.9 | -12.8 | -14.5 | -213 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -18.9 | 4.56 | -1.42 | 2.52 | 0.319 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -34 | -12.4 | -14.2 | -12 | -213 |
| Financing Cash Flow Items | -2.41 | -4.71 | -3.58 | -3.43 | -3.22 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -59.4 | -30.1 | -181 | -14.2 | 9.55 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 78.2 | 47.7 | -72.3 | 41.9 | -149 |